Indian regulator proposes draft framework for CROs
This article was originally published in SRA
Executive Summary
The Indian Central Drugs Standard Control Organization has issued the first-ever proposals to regulate the functioning of clinical research organisations that carry out clinical trials on behalf of pharmaceutical or medical device sponsors1. The agency recommends mandatory registration of all CROs – also known as contract research organisations – and lists the criteria for obtaining such registration.